229 related articles for article (PubMed ID: 37760635)
1. Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach.
Taylor AH; Konje JC; Ayakannu T
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760635
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation.
Maxwell GL; Hood BL; Day R; Chandran U; Kirchner D; Kolli VS; Bateman NW; Allard J; Miller C; Sun M; Flint MS; Zahn C; Oliver J; Banerjee S; Litzi T; Parwani A; Sandburg G; Rose S; Becich MJ; Berchuck A; Kohn E; Risinger JI; Conrads TP
Gynecol Oncol; 2011 Jun; 121(3):586-94. PubMed ID: 21458040
[TBL] [Abstract][Full Text] [Related]
3. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the proteomic signature of human endometrial receptivity.
Garrido-Gómez T; Quiñonero A; Antúnez O; Díaz-Gimeno P; Bellver J; Simón C; Domínguez F
Hum Reprod; 2014 Sep; 29(9):1957-67. PubMed ID: 25106620
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of PKM2 and HSPA5 as potential biomarkers for predicting high-risk endometrial carcinoma.
Teng Y; Ai Z; Wang Y; Wang J; Luo L
J Obstet Gynaecol Res; 2013 Jan; 39(1):317-25. PubMed ID: 22889453
[TBL] [Abstract][Full Text] [Related]
6. Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.
Martinez-Garcia E; Lesur A; Devis L; Cabrera S; Matias-Guiu X; Hirschfeld M; Asberger J; van Oostrum J; Casares de Cal MLÁ; Gómez-Tato A; Reventos J; Domon B; Colas E; Gil-Moreno A
Clin Cancer Res; 2017 Nov; 23(21):6458-6467. PubMed ID: 28790116
[No Abstract] [Full Text] [Related]
7. Proteomic Analysis of Endometrial Cancer Tissues from Patients with Type 2 Diabetes Mellitus.
Mujammami M; Rafiullah M; Alfadda AA; Akkour K; Alanazi IO; Masood A; Musambil M; Alhalal H; Arafah M; Rahman AMA; Benabdelkamel H
Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35454982
[TBL] [Abstract][Full Text] [Related]
8. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
[TBL] [Abstract][Full Text] [Related]
9. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
Hum Reprod; 2018 Mar; 33(3):399-410. PubMed ID: 29309596
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes.
Morelli M; Scumaci D; Di Cello A; Venturella R; Donato G; Faniello MC; Quaresima B; Cuda G; Zullo F; Costanzo F
Int J Gynecol Cancer; 2014 May; 24(4):649-58. PubMed ID: 24614826
[TBL] [Abstract][Full Text] [Related]
11. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive serum proteomic analysis in early endometrial cancer.
Uyar DS; Huang YW; Chesnik MA; Doan NB; Mirza SP
J Proteomics; 2021 Mar; 234():104099. PubMed ID: 33412313
[TBL] [Abstract][Full Text] [Related]
13. Differential proteomic analysis of endometrial fluid suggests increased inflammation and impaired glucose metabolism in non-implantative IVF cycles and pinpoints PYGB as a putative implantation marker.
Azkargorta M; Escobes I; Iloro I; Osinalde N; Corral B; Ibañez-Perez J; Exposito A; Prieto B; Elortza F; Matorras R
Hum Reprod; 2018 Oct; 33(10):1898-1906. PubMed ID: 30169642
[TBL] [Abstract][Full Text] [Related]
14. Novel molecular profiles of endometrial cancer-new light through old windows.
Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
[TBL] [Abstract][Full Text] [Related]
15. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
[TBL] [Abstract][Full Text] [Related]
16. Proteomic sift through serum and endometrium profiles unraveled signature proteins associated with subdued fertility and dampened endometrial receptivity in women with polycystic ovary syndrome.
Rashid N; Nigam A; Jain SK; Naqvi SH; Wajid S
Cell Tissue Res; 2020 Jun; 380(3):593-614. PubMed ID: 32052139
[TBL] [Abstract][Full Text] [Related]
17. Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer.
Akkour K; Alanazi IO; Alfadda AA; Alhalal H; Masood A; Musambil M; Rahman AMA; Alwehaibi MA; Arafah M; Bassi A; Benabdelkamel H
Cells; 2022 Jul; 11(13):. PubMed ID: 35805203
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
19. Expression of laminin-1 and matrix metalloproteinase-9 in benign and malignant endometrium.
Küçükaydın Z; Başaran M; Ünlü Y; Başaran A; Kurdoğlu M
Turk J Med Sci; 2023 Feb; 53(1):149-159. PubMed ID: 36945954
[TBL] [Abstract][Full Text] [Related]
20. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
Alkushi A; Köbel M; Kalloger SE; Gilks CB
Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
